What does this research mean for the field?

The new automated bridge assay for detecting thyroid-stimulating hormone receptor autoantibodies has high sensitivity (99.22%) and specificity (98.98%) for diagnosing Graves’ disease and discriminating it from other thyroid diseases. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

Evaluate a new automated assay for detecting thyroid-stimulating hormone receptor autoantibodies in Graves’ disease.

February 25, 2026Hormone and Metabolic Research

Clinical Evaluation of a New Automated Bridge Assay for the Detection of Thyroid-Stimulating Hormone Receptor Autoantibodies

View Full Paper

Ask AI

Bookmark

Evaluate a new automated assay for detecting thyroid-stimulating hormone receptor autoantibodies in Graves’ disease.
Clinical evaluation of a new bridge chemiluminescence assay.
Comparison with an established competition assay.
Included 132 Graves’ disease and other thyroid condition patients for analysis.
Used receiver-operating characteristic plot analysis to assess assay performance.
Achieved an area under the curve of 0.9994, indicating excellent test performance.
Optimal sensitivity of 99.22% and specificity of 98.98% at a cut-off level of 0.550 IU/L.
New assay detected more autoantibody-positive follow-up patients than the competition assay.
Autoantibody levels showed a steady decline during follow-up.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Evaluation of a new automated assay detects thyroid autoantibodies in Graves’ disease, indicating effective diagnosis and follow-up.

Cite This Study

Schott-Ohly et al. (2026) studied this question.

synapsesocial.com/papers/699e9143f5123be5ed04e9d7 https://doi.org/10.1055/a-2797-6441

View Full Paper

Ask AI

Bookmark

Clinical Evaluation of a New Automated Bridge Assay for the Detection of Thyroid-Stimulating Hormone Receptor Autoantibodies

Key Points

Discussion

Implication

Cite This Study

Clinical Evaluation of a New Automated Bridge Assay for the Detection of Thyroid-Stimulating Hormone Receptor Autoantibodies

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider